KRAS and adenoma: In the study of Yadamsuren et al., also analyzing Hungarian patients, 49.4% of the adenomas had KRAS mutation (57.5% of advanced adenomas, 31.0% of non-advanced adenomas) [67], while Juarez et al. found mutated KRAS in 11.6% of patients with conventional adenomas from a Spanish cohort [23].